Saturday, May 31, 2025

Latest

MediPharm Labs Posts Q3 Revenues of $5.4 Million, Continues To Post Negative Gross Margins

MediPharm Labs (TSX: LABS) this morning reported its third quarter financial results, posting revenues of $5.4 million for the quarter. The firm also posted a net loss of $7.4 million for the period.

Revenues were effectively flat for the the quarter, climbing from $5.1 million to $5.4 million on a quarter over quarter basis, while the firm still looks to improve upon its first quarter revenue figure of $5.5 million. Gross profit was again negative, a trend that has occurred all year, with the company posting a gross loss of $1.9 million.

Operating expenses further added to the losses, with general administrative expenses coming in at $4.6 million followed by marketing and selling expenses of $0.9 million. The firm overall posted an operating loss of $7.5 million, which resulted in a net loss of $7.5 million after a small $0.1 million income tax recovery.

Adjusted EBITDA meanwhile amounted to a loss of $5.6 million.

The firm also noted that its new CEO, Bryan Howcroft, is expected to start today, which is expected to improve international and pharmaceutical sales growth.

MediPharm Labs last traded at $0.315 on the TSX.


.Information for this briefing was found via Sedar and Medipharm Labs. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Leave a Reply

Video Articles

How To Profit From $3300 Gold? An Inside Look At A Massive 300,000 Oz Project | Martino De Ciccio

We’re At The Start of a Great Silver Boom | Ross McElroy & Andy Bowering – Apollo Silver Corp

Equinox Gold Q1 Earnings: When Everything Goes Wrong

Recommended

ESGold Begins Concentration Tests Ahead Of First Production

Sterling Metals Hits 0.21% Copper Over 482.8 Metres In First Drilling At Soo Copper project

Related News

Medipharm Labs Sees CEO Pat McCutcheon Step Down From Role, Remain As Chairman

Medipharm Labs (TSX: LABS) this morning announced drastic changes to its leadership role, with the...

Thursday, December 10, 2020, 07:38:42 AM

Medipharm Labs Sells Off Australian Assets

MediPharm Labs (TSX: LABS) appears to be slowly pulling back on its international endeavours. The...

Monday, July 11, 2022, 08:11:52 AM

Medipharm Labs Announces White Label Agreement, Provides No Details

Medipharm Labs (TSX: LABS) has entered into its second white label supply agreement with its...

Monday, May 4, 2020, 08:24:41 AM

MediPharm Labs Revenues Continue To Decline, Posts Negative Gross Margin

Medipharm Labs (TSX: LABS) this morning continued to show its desperate need for effective leadership....

Monday, August 16, 2021, 08:52:05 AM

Medipharm Labs: Canaccord Lowers Targets After Earnings

On August 16, Medipharm Labs (TSX: LABS) reported their second quarter financial results. The company...

Friday, August 20, 2021, 07:54:00 AM